Newsroom

Press releases

Bio-production: Fab’entech presents its new industrial site

Fab’entech, a French biotech specialised in the development and production of polyclonal antibodies, presents its new industrial site located in Saint-Priest, to the south-east of Lyon. The 1,000 m2 production site is now operational and will give Fab’entech the capacity to manufacture all of its innovations (biodefense and anti-COVID-19 programme: FabenCOV®) in France. Close-up of this new site, a key asset in the development of the biotech’s activities.

FIND OUT MORE

Sébastien Iva, new Chair of Fab’entech

Sébastien Iva is the new Chief Executive Officer of Fab’entech, a Lyon-based biotech created in 2009 and specialised in the development and production of polyclonal antibodies intended for the treatment of emerging infectious diseases and the development of biodefense solutions. His mission is to ensure its development and transformation, with the stated objective of becoming a key player in the field of polyclonal antibodies. He took over from Bertrand Lépine, founder of Fab’entech, who now becomes a member of the Supervisory Council.

FIND OUT MORE

Contact média

Agence Monet+Associés
Matthieu Mébarki – matthieu@monet-rp.com – 04 78 37 34 64
Mélanie Da Rui-Pons – mr@monet-rp.com – 06 58 98 85 75